Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annals of Hepatology
|
May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
Micropublication Biology
|
October 8, 2020
<i>C. elegans</i> CYLC-2 localizes to sperm
Amber R Krauchunas, Michael Werner, Nicholas Britt, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 5, 2024
Insights into periplasmic nitrate reductase function under single turnover
Jennifer McGarry, Breeanna Mintmier, Mikayla C Metzger, et al.
Pharmacotherapy
|
January 6, 2021
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
Melissa E Badowski, Nicholas Britt, Emily C Huesgen, et al.
Oncology Letters
|
August 11, 2022
<i>PTCH1</i> mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report
John T Dorsey, Ryan T Mott, Christopher M Lack, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Correlating ROS1 Protein Expression With <i>ROS1</i> Fusions, Amplifications, and Mutations
Richard S P Huang, Amanda Gottberg-Williams, Panhia Vang, et al.
Current Treatment Options in Oncology
|
June 23, 2018
Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas
Lori A Ramkissoon, Nicholas Britt, Alexander Guevara, et al.
The Oncologist
|
September 6, 2018
Genomic Landscape of Adult and Pediatric <i>BCR-ABL1</i>-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing
Eric A Severson, Jo-Anne Vergilio, Laurie M Gay, et al.
The Oncologist
|
September 12, 2020
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers
Andrew Rankin, Adrienne Johnson, Alison Roos, et al.
The Oncologist
|
February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response
Andge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annals of Hepatology
|
May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
Micropublication Biology
|
October 8, 2020
<i>C. elegans</i> CYLC-2 localizes to sperm
Amber R Krauchunas, Michael Werner, Nicholas Britt, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 5, 2024
Insights into periplasmic nitrate reductase function under single turnover
Jennifer McGarry, Breeanna Mintmier, Mikayla C Metzger, et al.
Pharmacotherapy
|
January 6, 2021
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
Melissa E Badowski, Nicholas Britt, Emily C Huesgen, et al.
Oncology Letters
|
August 11, 2022
<i>PTCH1</i> mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report
John T Dorsey, Ryan T Mott, Christopher M Lack, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Correlating ROS1 Protein Expression With <i>ROS1</i> Fusions, Amplifications, and Mutations
Richard S P Huang, Amanda Gottberg-Williams, Panhia Vang, et al.
Current Treatment Options in Oncology
|
June 23, 2018
Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas
Lori A Ramkissoon, Nicholas Britt, Alexander Guevara, et al.
The Oncologist
|
September 6, 2018
Genomic Landscape of Adult and Pediatric <i>BCR-ABL1</i>-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing
Eric A Severson, Jo-Anne Vergilio, Laurie M Gay, et al.
The Oncologist
|
September 12, 2020
Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers
Andrew Rankin, Adrienne Johnson, Alison Roos, et al.
The Oncologist
|
February 12, 2020
Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2-Year Durable Response
Andge Valiakhmetova, Sergey Gorelyshev, Alexander Konovalov, et al.
Page
of 2